GT 바이오파마GTBP 주가

Nasdaq Grants GT Biopharma Additional 180 Days To Regain Compliance

https://www.sec.gov/ix?doc=/Archives/edgar/data/109657/000149315226024913/form8-k.htm

[8-K] 중대 사건 — 8-K

GT Biopharma Q1 EPS $(0.11) Misses $(0.08) Estimate

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 66.67 percent increase over losses of $(0.33) per share from the

GT Biopharma Reports First Quarter 2026 Financial Results

Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with additional updates anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE® in multiple solid tumor types known to...

[10-Q] 분기 실적 — 10-Q

These stocks are moving in today's session

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.

What's going on in today's session

Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.

Which stocks are gapping on Thursday?

Let's have a look at the gap up and gap down stocks in today's session.

12 Health Care Stocks Moving In Thursday's Intraday Session

Discover the top movers in Thursday's pre-market session.

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.